This multi-signaling pathway uses both paracrine antiviral and juxtacrine neurogenic locus notch homolog protein 3 (NOTCH3) signaling to enhance breast cancer survival and therapy resistance. The gene discussed is NOTCH3; the disease is breast carcinoma.